Carl I. Schwartz, Chief Executive Officer at Precision Therapeutics Inc. (AIPT), bought 78,125 shares at $0.64 ($50K) on 2019-01-08, disclosed to the SEC on 2019-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AIPT | BUY | 2019-05-28 | $56K | — | Filing → |
| SGLB | BUY | 2019-05-24 | $560K | — | Filing → |
| SGLB | BUY | 2018-09-04 | $922K | — | Filing → |